Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.59 |
| ▸ | LMNA | P02545 | 2/20 | 0.59 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.53 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.51 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | CES2 | O00748 | 1/20 | 0.50 |
| ▸ | CES1 | P23141 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
| ▸ | ACHE | P22303 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL78754 | 1.00 | TSHR (0.62) | TSHRALDH1A1LMNAALOX15SIGMAR1 | |
| SCHEMBL81026 | 0.89 | TSHR (0.59) | TSHRALDH1A1LMNAALOX15SIGMAR1 | |
| SCHEMBL94846 | 0.85 | TSHR (0.67) | TSHRALDH1A1LMNAALOX15TRPV1 | |
| SCHEMBL30036663 | 0.85 | TSHR (0.67) | TSHRALDH1A1LMNAALOX15TRPV1 | |
| SCHEMBL30409059 | 0.84 | TSHR (0.53) | TSHRALDH1A1LMNAALOX15SIGMAR1 | |
| SCHEMBL21647739 | 0.84 | TSHR (0.53) | TSHRALDH1A1LMNAALOX15SIGMAR1 | |
| SCHEMBL28275071 | 0.84 | TSHR (0.61) | TSHRALDH1A1LMNAALOX15TRPV1 | |
| SCHEMBL15921150 | 0.83 | TSHR (0.65) | TSHRALDH1A1LMNASIGMAR1CYP1A2 | |
| SCHEMBL7399400 | 0.83 | TSHR (0.65) | TSHRALDH1A1LMNAALOX15SIGMAR1 | |
| SCHEMBL10490768 | 0.83 | TSHR (0.65) | TSHRALDH1A1LMNAALOX15TRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260071023-A1 | POLYESTER THERMOSETS FROM ESTER-CONTAINING EPOXY AND AMINE COMPONENTS | THE UNIVERSITY OF SOUTHERN MISSISSIPPI (US) | 2026-03-12 | — | — | US | disclosed |
| WO-2024030651-A1 | GPX4 INHIBITORS AND USE THEREOF | SONATA THERAPEUTICS, INC. (US) | 2024-02-08 | — | — | WO | disclosed |
| CN-112513011-B | Benzene derivatives | 小野药品工业株式会社 | 2023-06-16 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260071023-A1 | POLYESTER THERMOSETS FROM ESTER-CONTAINING EPOXY AND AMINE COMPONENTS | COL2A1, EBP, ZYX | TSHR 2571/4885ALDH1A1 1900/4885LMNA 565/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.